Tolterodine - a new bladder-selective antimuscarinic agent - II. Signal transduction pathways

Author： Nilvebrant L.   Andersson K.-E.   Gillberg P.-G.   Stahl M.   Sparf B.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.327, Iss.2, 1997-05, pp. : 195-207

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacotherapy for Overactive Bladder: An Evidence-Based Approach to Selecting an Antimuscarinic Agent

By Appell Rodney A.  

Drugs, Vol. 66, Iss. 10, 2006-01 ,pp. : 1361-1370

Adis International

Access to resources Recommend Favorite

The antimuscarinic agent solifenacin succinate can significantly improve symptoms of overactive bladder

By  

Inpharma, Vol. 1, Iss. 1430, 2004-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Cytosolic Calcium Oscillations in Signal Transduction Pathways

By  

Mini Reviews in Medicinal Chemistry, Vol. 2, Iss. 4, 2002-08 ,pp. : 353-360

Bentham Science Publishers

Access to resources Recommend Favorite

New Approaches to the Treatment of Inflammatory Disease: Focus on Small-Molecule Inhibitors of Signal Transduction Pathways

By Ivanenkov Y.A.  

Drugs in R&D, Vol. 9, Iss. 6, 2008-01 ,pp. : 397-434

Adis International

Access to resources Recommend Favorite

Simultaneous Interruption of Signal Transduction and Cell Cycle Regulatory Pathways: Implications for New Approaches to the Treatment of Childhood Leukemias

By  

Current Drug Targets, Vol. 8, Iss. 6, 2007-01 ,pp. : 751-759

Bentham Science Publishers

Access to resources Recommend Favorite